Literature DB >> 12453413

An iron delivery pathway mediated by a lipocalin.

Jun Yang1, David Goetz, Jau Yi Li, Wenge Wang, Kiyoshi Mori, Daria Setlik, Tonggong Du, Hediye Erdjument-Bromage, Paul Tempst, Roland Strong, Jonathan Barasch.   

Abstract

Despite the critical need for iron in many cellular reactions, deletion of the transferrin pathway does not block organogenesis, suggesting the presence of alternative methods to deliver iron. We show that a member of the lipocalin superfamily (24p3/Ngal) delivers iron to the cytoplasm where it activates or represses iron-responsive genes. Iron unloading depends on the cycling of 24p3/Ngal through acidic endosomes, but its pH sensitivity and its subcellular targeting differed from transferrin. Indeed, during the conversion of mesenchyme into epithelia (where we discovered the protein), 24p3/Ngal and transferrin were endocytosed by different cells that characterize different stages of development, and they triggered unique responses. These studies identify an iron delivery pathway active in development and cell physiology.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12453413     DOI: 10.1016/s1097-2765(02)00710-4

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  204 in total

1.  Lipocalin 2 is essential for chronic kidney disease progression in mice and humans.

Authors:  Amandine Viau; Khalil El Karoui; Denise Laouari; Martine Burtin; Clément Nguyen; Kiyoshi Mori; Evangéline Pillebout; Thorsten Berger; Tak Wah Mak; Bertrand Knebelmann; Gérard Friedlander; Jonathan Barasch; Fabiola Terzi
Journal:  J Clin Invest       Date:  2010-11       Impact factor: 14.808

2.  Diagnostic value of neutrophil gelatinase-associated lipocalin (NGAL) immunoexpression in follicular-patterned lesions of the thyroid gland.

Authors:  Valeria Barresi; Enrica Vitarelli; Luca Reggiani Bonetti; Giovanni Tuccari; Gaetano Barresi
Journal:  Virchows Arch       Date:  2012-02-28       Impact factor: 4.064

3.  The v-myc-induced Q83 lipocalin is a siderocalin.

Authors:  Nicolas Coudevylle; Leonhard Geist; Matthias Hötzinger; Markus Hartl; Georg Kontaxis; Klaus Bister; Robert Konrat
Journal:  J Biol Chem       Date:  2010-09-08       Impact factor: 5.157

4.  Bioinorganic chemistry: Getting a grip on iron.

Authors:  Caroline Philpott
Journal:  Nat Chem Biol       Date:  2010-08       Impact factor: 15.040

Review 5.  NGAL-Siderocalin in kidney disease.

Authors:  Neal Paragas; Andong Qiu; Maria Hollmen; Thomas L Nickolas; Prasad Devarajan; Jonathan Barasch
Journal:  Biochim Biophys Acta       Date:  2012-06-19

6.  Diet high in fructose leads to an overexpression of lipocalin-2 in rat fatty liver.

Authors:  Salamah Mohammad Alwahsh; Min Xu; Hatice Ali Seyhan; Shakil Ahmad; Sabine Mihm; Giuliano Ramadori; Frank Christian Schultze
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

7.  Lipocalin 2 promotes breast cancer progression.

Authors:  Jiang Yang; Diane R Bielenberg; Scott J Rodig; Robert Doiron; Matthew C Clifton; Andrew L Kung; Roland K Strong; David Zurakowski; Marsha A Moses
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-23       Impact factor: 11.205

Review 8.  Iron metabolism at the host pathogen interface: lipocalin 2 and the pathogen-associated iroA gene cluster.

Authors:  Kelly D Smith
Journal:  Int J Biochem Cell Biol       Date:  2007-07-18       Impact factor: 5.085

9.  Lipocalin-2 protein deficiency ameliorates experimental autoimmune encephalomyelitis: the pathogenic role of lipocalin-2 in the central nervous system and peripheral lymphoid tissues.

Authors:  Youngpyo Nam; Jong-Heon Kim; Minchul Seo; Jae-Hong Kim; Myungwon Jin; Sangmin Jeon; Jung-wan Seo; Won-Ha Lee; So Jin Bing; Youngheun Jee; Won Kee Lee; Dong Ho Park; Hyun Kook; Kyoungho Suk
Journal:  J Biol Chem       Date:  2014-05-07       Impact factor: 5.157

Review 10.  The SLC40 basolateral iron transporter family (IREG1/ferroportin/MTP1).

Authors:  Andrew T McKie; David J Barlow
Journal:  Pflugers Arch       Date:  2003-06-27       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.